Discover innovative biotechnology solutions with Precigen, Inc., a leader in synthetic biology in the pharmaceutical industry based in the United States. With a high-risk rating ESG score of 30.6, Precigen specializes in designing, building, and regulating gene programs that can be used across various end markets. Collaborating exclusively with industry experts, the company aims to bring new products and processes to market through its Biopharmaceuticals and Exemplar segments. Gain access to cutting-edge technologies and sustainable solutions with Precigen, Inc.